# Study of the Effect of Synchronised Anaemia Management in Chronic Kidney Disease

Study · id `cardio:ct-nct01763242` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01763242](<https://clinicaltrials.gov/study/NCT01763242>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01763242

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.

## Technical summary

Registry record NCT01763242. Randomized; no masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2012-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 102 participants (enrolled count; ClinicalTrials.gov record NCT01763242, source copy `cardio:ctgov-nct01763242-2013-01-08`, retrieved 2026-10-26)
- Start date: 2011-12 (registry gives no type) (ClinicalTrials.gov record NCT01763242, source copy `cardio:ctgov-nct01763242-2013-01-08`, retrieved 2026-10-26)
- Primary completion: 2012-12 (actual) (ClinicalTrials.gov record NCT01763242, source copy `cardio:ctgov-nct01763242-2013-01-08`, retrieved 2026-10-26)
- Completion: 2012-12 (actual) (ClinicalTrials.gov record NCT01763242, source copy `cardio:ctgov-nct01763242-2013-01-08`, retrieved 2026-10-26)
- Countries: Australia (ClinicalTrials.gov record NCT01763242, source copy `cardio:ctgov-nct01763242-2013-01-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01763242-2013-01-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of the Effect of Synchronised Anaemia Management in Chronic Kidney Disease
- Acronym: EMAN-Anaemia
- Condition: Kidney Failure, Chronic
- Condition: Anemia
- Intervention (Other): EMAN
- Lead sponsor: Western Health, Australia
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: ae55858b3a305c8a2801578de2d962f8cd4be9b79063d23854a67d2fb522da22
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
